Private Shareholders

Being a Shareholder

As a Sanofi shareholder, you own a share in our capital, providing us with the resources we need to grow. By investing in our future, you are giving us a vote of confidence. Confidence is the cornerstone of the special relationship between us and our shareholders. We are committed to retaining and building your confidence by involving you in our development and giving you a share of our profits.

Anthony Van Poucke, Associate Scientist, Ghent, Belgium

Third Quarter 2024 Results

“Our strong performance continues in Q3, boosted by sales of flu and RSV vaccines, the steady progress of our new pharma launches, and the continued momentum of our best-in-class biologic, now approved in six type 2 inflammatory diseases and treating more than 1 million patients worldwide.”

Paul Hudson, Chief Executive Officer

Our Pipeline

5

Therapeutic areas

78

Compounds in clinical development

27

Clinical trials in phase 3

Sanofi France – Key figures

How to Hold Sanofi Shares

Sanofi ordinary shares can be held as:

  • Bearer shares: deposited with your financial intermediary,
  • Administered registered shares: deposited with your financial intermediary and recorded in the books of Sanofi,
  • Fully registered shares: deposited with and administered by Uptevia, transfer agent appointed by Sanofi. You benefit in this case from preferential rates for brokerage fees & bank commission and double voting rights when you have held your shares for at least two years

Uptevia fees for holding pure registered securities:

  • Free custody and administration fees
  • Bank commission of 7.62 euros per order
  • Brokerage fee: 0.45% with a minimum of 6.10 euros per order
Paul Hudson speaking at the Annual General Meeting 2024

Annual General Meeting 2024

The Sanofi General Meeting was held on April 30, 2024. 

Frequently Asked Questions From Individual Shareholders

In-Depth Reading

Shares